Ubique Bio
Ubique Biotech is a biotech startup founded in 2022 that develops AI-driven synthetic reagents for precision diagnostics, integrated into ELISA and rapid point-of-care tests. Their technology enables affordable, scalable, and accurate antigen and antibody testing for large-scale disease screening, prioritizing accessibility and sustainability. With operations in the USA, Mexico, and Argentina, they focus on revolutionizing diagnostics to make healthcare accessible globally, partnering with test developers, health companies, and governments to deploy innovative diagnostic solutions.
Ubique Bio
Ubique Biotech is a biotech startup founded in 2022 that develops AI-driven synthetic reagents for precision diagnostics, integrated into ELISA and rapid point-of-care tests. Their technology enables affordable, scalable, and accurate antigen and antibody testing for large-scale disease screening, prioritizing accessibility and sustainability. With operations in the USA, Mexico, and Argentina, they focus on revolutionizing diagnostics to make healthcare accessible globally, partnering with test developers, health companies, and governments to deploy innovative diagnostic solutions.